Journal of Kidney Cancer and VHL
Codon Publications · Australia · Est. 1981
✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.
See the official Impact Factor & quartile on the journal’s page ↗The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Source: Clarivate Journal Citation Reports.
Aims & Scope
Journal of Kidney Cancer (ISSN: 2203-5826) is a peer-reviewed, online-only, open access journal dedicated for the dissemination of research findings in kidney cancer and VHL. Kidney cancer, also known as renal cell carcinoma, is relatively rare representing approximately 2% of all cancers. Aberrations in the von Hippel-Lindau gene (VHL) are the major risk factors for the development of kidney cancer. VHL aberrations, by themselves, also cause another rare condition called VHL syndrome. The incidence of VHL syndrome is estimated to be 1 in 36,000 individuals. Journal of Kidney Cancer aims to be a scholarly forum for the exchange of knowledge which will enable scientists to develop better treatment strategies for the management of these two disorders. The journal will publish basic science and clinical research articles on all aspects of kidney cancer and VHL. Original articles, comprehensive reviews, case reports, short communications, and letter to the editor are suitable for submission.
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Web of Science Categories
Research Topics (OpenAlex)
Frequently asked questions about Journal of Kidney Cancer and VHL
Is Journal of Kidney Cancer and VHL a predatory journal?
PubScope has no integrity flags on record for Journal of Kidney Cancer and VHL: it is indexed in Web of Science, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Journal of Kidney Cancer and VHL?
Journal of Kidney Cancer and VHL is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.11.
Is Journal of Kidney Cancer and VHL indexed in Scopus and Web of Science?
Journal of Kidney Cancer and VHL is indexed in Web of Science, DOAJ.
What is the aims and scope of Journal of Kidney Cancer and VHL?
Journal of Kidney Cancer (ISSN: 2203-5826) is a peer-reviewed, online-only, open access journal dedicated for the dissemination of research findings in kidney cancer and VHL. Kidney cancer, also known as renal cell carcinoma, is relatively rare representing approximately 2% of all cancers. Aberrations in the von Hippel-Lindau gene (VHL) are the major risk factors for the development of kidney cancer. VHL aberrations, by themselves, also cause another rare condition called VHL syndrome. The incidence of VHL syndrome is estimated to be 1 in 36,000 individuals. Journal of Kidney Cancer &nbs
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref